BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6608924)

  • 1. Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27.
    Pease CT; Fordham JN; Currey HL
    Ann Rheum Dis; 1984 Apr; 43(2):279-84. PubMed ID: 6608924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-B27, ankylosing spondylitis and polymorph motility.
    Pease CT; Currey HL
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):172-6. PubMed ID: 6606471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients.
    Biasi D; Carletto A; Caramaschi P; Bellavite P; Andrioli G; Caraffi M; Pacor ML; Bambara LM
    Clin Exp Rheumatol; 1995; 13(5):623-7. PubMed ID: 8575141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphonuclear leucocyte motility in men with ankylosing spondylitis.
    Pease CT; Fennell M; Brewerton DA
    Ann Rheum Dis; 1989 Jan; 48(1):35-41. PubMed ID: 2784306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.
    Repo H; Leirisalo M; Tiilikainen A; Laitinen O
    Arthritis Rheum; 1982 Jun; 25(6):655-61. PubMed ID: 6980007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute anterior uveitis, ankylosing spondylitis, back pain, and HLA-B27.
    Beckingsale AB; Davies J; Gibson JM; Rosenthal AR
    Br J Ophthalmol; 1984 Oct; 68(10):741-5. PubMed ID: 6236842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-B27 and ankylosing spondylitis: an anti-idiotypic model.
    McLean IL; Adams DD; Highton J
    J Clin Lab Immunol; 1985 Nov; 18(3):123-7. PubMed ID: 3878886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of HLA associated disease: ankylosing spondylitis.
    Hammoudeh M; Khan MA
    J Rheumatol; 1983 Apr; 10(2):301-4. PubMed ID: 6602883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B27 haplotypes in family studies of ankylosing spondylitis.
    Lochead JA; Chalmers IM; Marshall WH; Larsen B; Skanes VM; Payne RH; Barnard JM
    Arthritis Rheum; 1983 Aug; 26(8):1011-6. PubMed ID: 6603847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exaggerated inflammatory responsiveness plays a part in the pathogenesis of HLA-B27 linked diseases--hypothesis.
    Repo H; Leirisalo-Repo M; Koivuranta-Vaara P
    Ann Clin Res; 1984; 16(1):47-50. PubMed ID: 6378047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of HLA class I expression in ankylosing spondylitis.
    Creamer P; Edmonds J; Sullivan J; Matthews S
    Ann Rheum Dis; 1992 Oct; 51(10):1138-42. PubMed ID: 1444627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance between HLA-B27 and ankylosing spondylitis: a family investigation.
    Gladman DD; Urowitz MB; Anhorn KA; Chalmers A; Mervart H
    J Rheumatol; 1986 Feb; 13(1):129-36. PubMed ID: 3486283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.
    Repo H; Koivuranta-Vaara P; Leirisalo-Repo M
    Ann Rheum Dis; 1988 Jun; 47(6):452-7. PubMed ID: 2838004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of HLA antigens A and B and their cross reactions in B27-negative ankylosing spondylarthritis].
    Dreyfus P; Geay D; Cambon H; Daupleix D
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):269-72. PubMed ID: 6610919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance].
    Ebringer A
    Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population.
    Archer JR; Stubbs MM; Currey HL; Geczy AF
    Lancet; 1985 Feb; 1(8424):344-5. PubMed ID: 2857398
    [No Abstract]   [Full Text] [Related]  

  • 17. [Incidence of ankylosing spondylitis in persons with the HLA-B27 antigen].
    Jajić I; Bastasić M; Kerhin V
    Reumatizam; 1984; 31(3-4):49-52. PubMed ID: 6334341
    [No Abstract]   [Full Text] [Related]  

  • 18. Two-dimensional gel analysis demonstrates no structural alteration of HLA-B27 polypeptides between patients with ankylosing spondylitis and healthy individuals.
    Trapani JA; Walker ID; McKenzie IF
    Ann Rheum Dis; 1984 Apr; 43(2):177-80. PubMed ID: 6608922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA-B27 antigen and ankylosing spondylitis].
    Bastasić M; Jajić I; Kerhin-Brkljacić V
    Vojnosanit Pregl; 1983; 40(4):269-71. PubMed ID: 6606263
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevalence of HLA-B27 antigen and ankylosing spondylitis in an urban population].
    Jajić Z; Jajić I
    Reumatizam; 1986; 33(3-4):84-6. PubMed ID: 3502030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.